American Gene Technologies International Inc.
4 clinical trials · Sponsor
◉ Watch American Gene Technologies International Inc.
| Record | Firm | Date |
|---|---|---|
| Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T (NCT05529342) | American Gene Technologies International Inc. | 2022-08-29 |
| An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy (NCT05540964) | American Gene Technologies International Inc. | 2022-07-19 |
| Study to Evaluate the Safety of a Gene and Cell Therapy Product in Participants With HIV That is Well-Controlled on Antiretroviral Therapy (NCT04561258) | American Gene Technologies International Inc. | 2020-10-12 |
Track American Gene Technologies International Inc. automatically
Every clearance here is in the API, with alerts when new ones post.